Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BolA family member 3 pseudogene 3 (BOLA3P3) is annotated as a pseudogene, meaning it is a nonfunctional DNA segment that shows sequence similarity to the protein-coding BOLA3 gene but does not produce a functional protein product[3][4]. Like other pseudogenes, BOLA3P3 is considered a genomic remnant and does not play a direct role in encoding proteins or serving as a typical therapeutic target[2][5]. While most pseudogenes are transcriptionally silent and functionally inert, some pseudogenes are known to have rare regulatory roles as non-coding RNAs or may act as sources of genetic diversity; however, no such function has been documented for BOLA3P3 specifically[2][5]. There are no known drugs, disease associations, or safety risks tied to BOLA3P3. It should not be confused with the functional BolA family member 3 (BOLA3) gene, which is involved in mitochondrial iron-sulfur cluster assembly and associated metabolic diseases[1].
None (pseudogene, not druggable)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BolA family member 3 pseudogene 3 (BOLA3P3).